Ovid Therapeutics Inc.
NASDAQ: OVID0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Margaret Alexander
- Employees
- 23
- Headquarters
- New York City, United States
- IPO year
- 2017
- Market cap
- $329.7M
- Website
- https://www.ovidrx.com
Loading OVID…
Loading profile data…Frequently asked questions about OVID
What does Ovid Therapeutics Inc. (OVID) do?
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X sy...
Where does OVID trade?
Ovid Therapeutics Inc. (OVID) trades on the NASDAQ Global Select.
What sector is OVID in?
Ovid Therapeutics Inc. (OVID) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ovid Therapeutics Inc.?
Margaret Alexander is the chief executive officer of Ovid Therapeutics Inc. (OVID).
Where is Ovid Therapeutics Inc. headquartered?
Ovid Therapeutics Inc. is headquartered in United States.
Does OVID pay a dividend?
Ovid Therapeutics Inc. (OVID) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OVID go public?
Ovid Therapeutics Inc. (OVID) completed its initial public offering in 2017.